Menopause Hormone Therapy (HRT) in La Crosse, WI

Bioidentical hormones in La Crosse: what it means

"Bioidentical" is a word compounding pharmacies often use in marketing, but what it describes is real: a hormone built like the body's own. Estradiol, the main estrogen the ovaries make before menopause, and micronized progesterone both fit that description. FDA-approved versions of both are sold by prescription at retail pharmacies.

"BHRT" often means compounded hormones, a cream, a blend such as Bi-Est or a pellet that a pharmacy mixes for one prescription. Compounded drugs are not FDA-approved, so the FDA cannot assure their safety, effectiveness or dose. The FDA says it has no evidence that compounded "bioidentical hormones" are safe and effective, or more effective than FDA-approved hormone therapy. When the National Academies reviewed them in 2020, the evidence was mostly low quality, such as anecdotes and patient reports.

La Crosse is a center for OB-GYN care: the federal NPI registry lists 26 OB-GYNs with a primary practice address in the city, 50.2 per 100,000 residents, 2.8 times the US rate of 17.8 and above Wisconsin's 16.5. That is more per resident than 85% of the 924 cities VevaMD covers. Set against the city's 4,268 women aged 45 to 64, that is one OB-GYN for roughly every 160.

Within 10 miles of the city there are 34 OB-GYNs, and within 25 miles 37, about 16.9 per 100,000 of the 218,621 residents in that radius. Whether or not you have an OB-GYN, you can ask a physician licensed in Wisconsin about menopause hormone therapy online from La Crosse, with no waiting room.

Through VevaMD, a physician licensed in Wisconsin decides whether hormone therapy fits you and, if so, the form: an estradiol pill, patch, cream or vaginal cream, with progesterone if you have a uterus. There are no pellets. Because the dispensing pharmacy also compounds, you can ask whether your estradiol or progesterone is an FDA-approved product. Testosterone cream for women and Bi-Est are compounded and not FDA-approved.

A pellet clinic is a different model: it implants a hormone pellet under the skin during a visit, and compounded pellets are not FDA-approved. The Endocrine Society cites blood levels well above the expected range in women using compounded pellets. ACOG's guidance is to prefer FDA-approved menopause hormone therapy to compounded hormones.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11